Sancilio Pharmaceuticals last week withdrew its plans for an initial public offering it hoped would bring in $86 million for its Advanced Lipid Technology drug delivery platform. The Florida-based company registered the IPO in August 2015, but today requested that the SEC consent to its withdrawal, without giving a specific reason. The company’s drug delivery […]
Funding Roundup
Credence MedSystems raises $15m for safe-syringe drug delivery
Credence MedSystems announced today that it raised $15 million in a Series A round to fund continued development and commercialization of its injectable drug-delivery device. The company’s flagship device is the Credence Companion safety syringe, a pre-fillable device sold to drug manufacturers for use with injectable medications. The user injects their medication, gets a cue […]
Chrono Therapeutics closes $48m Series B for smart nicotine patch
Hayward, Calif.-based startup Chrono Therapeutics reportedly raised $47.6m in a Series B round, led by Kaiser Permanente Ventures. The money, Chrono CEO Alan Levy told Forbes, is to fund clinical trials of a transdermal smoking cessation patch. The company is preparing for a large, Phase II efficacy study of the technology. Unlike normal nicotine patches, Chrono said […]
